carbamates has been researched along with Dermatoses in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Safety assessments included monitoring treatment-emergent adverse events (TEAEs) and serious adverse events (SAEs)." | 2.94 | Safety of retigabine in adults with partial-onset seizures after long-term exposure: focus on unexpected ophthalmological and dermatological events. ( Boll, MC; Brickel, N; Cooper, J; Daniluk, J; De'Ath, J; Hewett, K; Joshi, K; McDonald, S; Rayner, K; Tiamkao, S; Vorobyeva, O, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brickel, N | 1 |
| Hewett, K | 1 |
| Rayner, K | 1 |
| McDonald, S | 1 |
| De'Ath, J | 1 |
| Daniluk, J | 1 |
| Joshi, K | 1 |
| Boll, MC | 1 |
| Tiamkao, S | 1 |
| Vorobyeva, O | 1 |
| Cooper, J | 1 |
| Daud, A | 1 |
| Tsai, K | 1 |
| Russo, I | 1 |
| Zorzetto, L | 1 |
| Frigo, AC | 1 |
| Chiarion Sileni, V | 1 |
| Alaibac, M | 1 |
| Benavente-Villegas, F | 1 |
| Díaz-Corpas, T | 1 |
| García-Briz, M | 1 |
| Moneva-Léniz, L | 1 |
| Sánchez-Motilla, J | 1 |
| Prats-Máñez, A | 1 |
| Fuertes-Prosper, A | 1 |
| Soriano-Sarrió, P | 1 |
| Belum, VR | 1 |
| Rosen, AC | 1 |
| Jaimes, N | 1 |
| Dranitsaris, G | 1 |
| Pulitzer, MP | 1 |
| Busam, KJ | 1 |
| Marghoob, AA | 1 |
| Carvajal, RD | 1 |
| Chapman, PB | 1 |
| Lacouture, ME | 1 |
| Fagrell, B | 1 |
| Füller, H | 1 |
| Guthrie, FE | 1 |
| Domanski, JJ | 1 |
| Main, AR | 1 |
| Sanders, DG | 1 |
| Monroe, RR | 1 |
| Inoue, K | 1 |
| Matsumura, M | 1 |
| Swanbeck, G | 1 |
1 review available for carbamates and Dermatoses
| Article | Year |
|---|---|
Management of Treatment-Related Adverse Events with Agents Targeting the MAPK Pathway in Patients with Metastatic Melanoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azetidines; Benzimidazoles; C | 2017 |
2 trials available for carbamates and Dermatoses
| Article | Year |
|---|---|
Safety of retigabine in adults with partial-onset seizures after long-term exposure: focus on unexpected ophthalmological and dermatological events.
Topics: Adult; Anticonvulsants; Carbamates; Double-Blind Method; Drug Administration Schedule; Drug Therapy, | 2020 |
The effect of pyridinolcarbamate on the skin microcirculation in patients with severe skin necroses. A double-blind trial study.
Topics: Aged; Carbamates; Female; Humans; Male; Microcirculation; Necrosis; Pyridinolcarbamate; Skin; Skin D | 1976 |
7 other studies available for carbamates and Dermatoses
| Article | Year |
|---|---|
A comparative study of the cutaneous side effects between BRAF monotherapy and BRAF/MEK inhibitor combination therapy in patients with advanced melanoma: a single-centre experience.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carbamates; Humans; Imidazole | 2017 |
Topics: Adult; Aged; Carbamates; Coloring Agents; Diagnosis, Differential; Female; Granuloma; Humans; Hypers | 2018 |
Clinico-morphological features of BRAF inhibition-induced proliferative skin lesions in cancer patients.
Topics: Adult; Aged; Benzimidazoles; Carbamates; Female; Humans; Imidazoles; Indoles; Male; Middle Aged; Neo | 2015 |
[Practical experiences with Ertolan].
Topics: Acne Vulgaris; Carbamates; Eczema; Fluorine; Histamine H1 Antagonists; Humans; Prednisolone; Psorias | 1967 |
Use of mice for initial approximation of reentry intervals into pesticide-treated fields.
Topics: Animals; Azinphosmethyl; Carbamates; Cholinesterase Inhibitors; Cholinesterases; Chromatography, Gas | 1974 |
[Diabetic skin disease and its treatment].
Topics: Adult; Carbamates; Diabetes Complications; Female; Humans; Male; Middle Aged; Skin Diseases | 1971 |
[Dermatologic topical treatment. 9. Hyperkeratoses and rhagades].
Topics: Aspirin; Carbamates; Humans; Keratosis; Skin Diseases | 1971 |